Arrhythmogenic right ventricular dysplasia

Revision as of 15:40, 23 July 2016 by Neil.m.young (talk | contribs) (Text replacement - "==Diagnosis==" to "==Evaluation==")

Background

  • ARVD is a significant contributor to sudden cardiac death in young patients
  • More common in males and those of Mediterranean descent
  • 1:1000-10,000 in the US
  • Fibro-fatty replacement of myocardium

Clinical Features

  • Syncope
  • Ventricular dysrhythmia/cardiac arrest
  • Family history of unexplained syncope or sudden death
  • Dysrhythmias refractory to anti-dysrhythmic meds

Differential Diagnosis

Cardiomyopathy

Syncope Causes

T Wave Inversions

Evaluation

ECG

ARVD.png

  • Epsilon wave, 30-50%
  • V1-V3 TWI (especially in patients >14 yrs old), 85%
  • V1-V3 QRS widening
  • Sudden VT episodes with a LBBB morphology

Imaging

Major and minor criteria rely on echo and cardiac MRI

  • Echo - hypokinetic and dilated RV, dilation of RVOT
  • Cardiac MRI - fibro-fatty change with RV myocardial thinning, RV aneurysms, RV dilatation

Management

  • Sotalol is the preferred anti-dysrhythmic
  • Manage heart failure in the usual manner

Disposition

  • Symptomatic presentation: Admission to cardiology
  • Incidental finding: Cardiology follow-up for further risk assessment and possible ICD placement or ablation

References

  • Anderson EL. Arrhythmogenic right ventricular dysplasia. Am Fam Physician. 2006 Apr 15;73(8):1391-8.
  • Perez Diez D, Brugada J. Diagnosis and Management of Arrhythmogenic Right Ventricular Dysplasia. E-Journal of the ESC Council for Cardiology Practice, European Society of Cardiology 2008.